Human Autoantibodies Reactive with Synthetic Autoantigens from T-Cell Receptor β Chain
We used mapping with synthetic overlapping peptides in combination with molecular modeling to analyze the IgG antibodies that humans naturally produce against human T-cell receptor β chains and to localize the recognized peptide autoantigens in the three-dimensional structure of the molecule. Health...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 89; no. 8; pp. 3325 - 3329 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
National Academy of Sciences of the United States of America
15.04.1992
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We used mapping with synthetic overlapping peptides in combination with molecular modeling to analyze the IgG antibodies that humans naturally produce against human T-cell receptor β chains and to localize the recognized peptide autoantigens in the three-dimensional structure of the molecule. Healthy individuals produce low levels of antibodies against T-cell receptor peptides, and these can be increased in autoimmune diseases. We characterized the reactivities in detail because IgG molecules reactive with self peptides occur in preparations of intravenous immunoglobulin and can be isolated by immunoaffinity chromatography. Natural IgG antibodies were directed against three major peptides. One corresponds to the first complementarity-determining region of the variable region. A second corresponds to the third framework of the variable region. The third is located in the constant region and is predicted to be a loop that extends out of the β-barrel structure. This peptide is one that would give a characteristic structural distinction between the β-chain constant region and the constant regions of immunoglobulin light chains to which β chains are homologous. The capacity to bind these peptides is found in small fractions of normal polyclonal IgG, which contains both κ chains and λ chains. The activity is antibody-like in being confined to the Fab fragment and in its capacity to discriminate among homologous synthetic peptides corresponding to distinct β-chain variable-region genes. We propose that a recognition and regulatory process naturally occurs that parallels the immune network for the regulation of the production of antibodies. |
---|---|
AbstractList | We used mapping with synthetic overlapping peptides in combination with molecular modeling to analyze the IgG antibodies that humans naturally produce against human T-cell receptor beta chains and to localize the recognized peptide autoantigens in the three-dimensional structure of the molecule. Healthy individuals produce low levels of antibodies against T-cell receptor peptides, and these can be increased in autoimmune diseases. We characterized the reactivities in detail because IgG molecules reactive with self peptides occur in preparations of intravenous immunoglobulin and can be isolated by immunoaffinity chromatography. Natural IgG antibodies were directed against three major peptides. One corresponds to the first complementarity-determining region of the variable region. A second corresponds to the third framework of the variable region. The third is located in the constant region and is predicted to be a loop that extends out of the beta-barrel structure. This peptide is one that would give a characteristic structural distinction between the beta-chain constant region and the constant regions of immunoglobulin light chains to which beta chains are homologous. The capacity to bind these peptides is found in small fractions of normal polyclonal IgG, which contains both kappa chains and lambda chains. The activity is antibody-like in being confined to the Fab fragment and in its capacity to discriminate among homologous synthetic peptides corresponding to distinct beta-chain variable-region genes. We propose that a recognition and regulatory process naturally occurs that parallels the immune network for the regulation of the production of antibodies. We used mapping with synthetic overlapping peptides in combination with molecular modeling to analyze the IgG antibodies that humans naturally produce against human T-cell receptor β chains and to localize the recognized peptide autoantigens in the three-dimensional structure of the molecule. Healthy individuals produce low levels of antibodies against T-cell receptor peptides, and these can be increased in autoimmune diseases. We characterized the reactivities in detail because IgG molecules reactive with self peptides occur in preparations of intravenous immunoglobulin and can be isolated by immunoaffinity chromatography. Natural IgG antibodies were directed against three major peptides. One corresponds to the first complementarity-determining region of the variable region. A second corresponds to the third framework of the variable region. The third is located in the constant region and is predicted to be a loop that extends out of the β-barrel structure. This peptide is one that would give a characteristic structural distinction between the β-chain constant region and the constant regions of immunoglobulin light chains to which β chains are homologous. The capacity to bind these peptides is found in small fractions of normal polyclonal IgG, which contains both κ chains and λ chains. The activity is antibody-like in being confined to the Fab fragment and in its capacity to discriminate among homologous synthetic peptides corresponding to distinct β-chain variable-region genes. We propose that a recognition and regulatory process naturally occurs that parallels the immune network for the regulation of the production of antibodies. |
Author | Marchalonis, John J. Kaymaz, Hulya Schluter, Samuel F. Edmundson, Allen B. Dedeoglu, Fatma Yocum, David E. |
AuthorAffiliation | Department of Microbiology and Immunology, College of Medicine, University of Arizona, Tucson 85724 |
AuthorAffiliation_xml | – name: Department of Microbiology and Immunology, College of Medicine, University of Arizona, Tucson 85724 |
Author_xml | – sequence: 1 givenname: John J. surname: Marchalonis fullname: Marchalonis, John J. – sequence: 2 givenname: Hulya surname: Kaymaz fullname: Kaymaz, Hulya – sequence: 3 givenname: Fatma surname: Dedeoglu fullname: Dedeoglu, Fatma – sequence: 4 givenname: Samuel F. surname: Schluter fullname: Schluter, Samuel F. – sequence: 5 givenname: David E. surname: Yocum fullname: Yocum, David E. – sequence: 6 givenname: Allen B. surname: Edmundson fullname: Edmundson, Allen B. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5284216$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/1565623$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1uEzEUhS1UVNLSLSuQZoG6m8G_M7bEpooKRaqEBEVdWo5zp3E1YwfbU9rX4kF4JhwlhLBh5cX5zrnXPj5BRz54QOgVwQ3BHXu39iY1UjWyYYyKZ2hGsCJ1yxU-QjOMaVdLTvkLdJLSPcZYCYmP0TERrWgpm6Hbq2k0vrqYcjA-u0VYOkjVFzA2uweofri8qr4--byC7OweuwOfqj6Gsbqp5zAMxWBhnUOsfv2s5ivj_Ev0vDdDgrPdeYq-fbi8mV_V158_fppfXNdWMJJrBbalRmBpyqpSLECQrmyJ-5bLHqxcWuiAW8swYS1jLQW-NJZ30AkpiZHsFL3f5q6nxQgF9zmaQa-jG0180sE4_a_i3UrfhQfNpRSq2M939hi-T5CyHl2y5UbGQ5iS7qjChEtewGYL2hhSitDvRxCsN0XoTRFaKi31pohieHO42F98-_JFf7vTTbJm6KPx1qU9JmipjbQHMZv4P-rhmPP_6bqfhiHDYy7g6y14n0pPe5IyocqHYb8BTAC1sQ |
CODEN | PNASA6 |
CitedBy_id | crossref_primary_10_1097_00007890_199809270_00017 crossref_primary_10_1016_j_jneuroim_2011_02_006 crossref_primary_10_1097_00013542_200207000_00001 crossref_primary_10_1007_s00415_006_5003_1 crossref_primary_10_1097_01_TP_0000080685_31697_FC crossref_primary_10_1177_135245859700300211 crossref_primary_10_1002_rmb2_12078 crossref_primary_10_3109_s10165_007_0013_0 crossref_primary_10_1007_s00415_005_1102_7 crossref_primary_10_1007_BF02787711 crossref_primary_10_1111_j_1744_9987_1997_tb00011_x crossref_primary_10_1111_j_1749_6632_1997_tb52101_x crossref_primary_10_1007_BF01024924 crossref_primary_10_1023_A_1026361110795 crossref_primary_10_1002_ajh_1141 crossref_primary_10_1172_JCI200316039 crossref_primary_10_1016_j_clim_2009_04_002 crossref_primary_10_1182_blood_V93_11_3624 crossref_primary_10_1097_00007890_200009270_00006 crossref_primary_10_1002__SICI_1099_1352_199905_06_12_3_169__AID_JMR459_3_0_CO_2_6 crossref_primary_10_1111_j_1399_3038_1994_tb00230_x crossref_primary_10_1007_s10875_014_0024_5 crossref_primary_10_1097_01_TP_0000122415_08639_53 crossref_primary_10_1111_j_1749_6632_1994_tb33557_x crossref_primary_10_1016_j_mehy_2021_110592 crossref_primary_10_1046_j_1365_2567_2002_01545_x crossref_primary_10_1212_WNL_59_12_suppl_6_S13 crossref_primary_10_1046_j_1365_2567_1998_00470_x crossref_primary_10_1093_jn_126_5_1389 crossref_primary_10_3109_08830189809054409 crossref_primary_10_1016_S0165_5728_01_00243_0 crossref_primary_10_1016_j_dci_2005_06_011 crossref_primary_10_1034_j_1398_9995_2003_00239_x crossref_primary_10_1172_JCI200522753 crossref_primary_10_1191_0961203304lu2011oa crossref_primary_10_1016_S0022_1759_98_00074_X crossref_primary_10_1038_nri3401 crossref_primary_10_1002_jmr_586 crossref_primary_10_1034_j_1600_6143_2003_00121_x crossref_primary_10_1136_jnnp_57_Suppl_6 crossref_primary_10_1023_B_JOPC_0000020077_73751_76 crossref_primary_10_1007_s13311_015_0391_5 crossref_primary_10_1002_mus_20076 crossref_primary_10_1016_j_bbi_2020_04_046 crossref_primary_10_1111_j_1600_065X_1994_tb00856_x crossref_primary_10_3389_fimmu_2022_901872 crossref_primary_10_1016_j_tracli_2007_04_003 crossref_primary_10_1146_annurev_immunol_26_021607_090232 crossref_primary_10_1007_s13311_021_01108_4 crossref_primary_10_1007_s10875_007_9088_9 crossref_primary_10_1097_TP_0b013e3181dd6bf1 crossref_primary_10_1096_fj_01_0884com crossref_primary_10_1182_blood_2002_05_1447 crossref_primary_10_1016_j_jneuroim_2009_10_007 crossref_primary_10_1002__SICI_1097_4547_19960215_43_4_391__AID_JNR1_3_0_CO_2_A crossref_primary_10_1016_j_tips_2013_05_009 crossref_primary_10_1034_j_1600_6143_2003_00011_x crossref_primary_10_1093_cid_ciz1030 crossref_primary_10_1182_blood_V93_11_3624_411a28_3624_3631 crossref_primary_10_1111_j_1365_3083_2005_01568_x crossref_primary_10_1111_cei_1996_104_s1_71 crossref_primary_10_1016_j_cyto_2007_12_007 crossref_primary_10_1056_NEJMra993360 crossref_primary_10_1111_j_1600_0609_2004_00350_x crossref_primary_10_4254_wjh_v7_i11_1494 crossref_primary_10_1016_S0306_3623_98_00004_4 crossref_primary_10_1016_j_emch_2004_08_003 crossref_primary_10_1046_j_1365_2567_2002_01389_x crossref_primary_10_1002_eji_201444700 crossref_primary_10_1016_S0248_8663_00_88673_7 crossref_primary_10_1056_NEJMra1009433 crossref_primary_10_1007_BF02918365 crossref_primary_10_1097_00007890_200108150_00010 crossref_primary_10_1002_jmr_527 crossref_primary_10_1111_j_1749_6632_1994_tb33559_x crossref_primary_10_1196_annals_1356_019 crossref_primary_10_1007_s00415_006_5013_z crossref_primary_10_1023_A_1007086608036 crossref_primary_10_1016_j_tmrv_2007_12_001 crossref_primary_10_1096_fj_01_0953hyp crossref_primary_10_1016_S1155_1984_04_40050_8 crossref_primary_10_1111_j_1399_3046_2005_00256_x crossref_primary_10_1177_120347549800300209 crossref_primary_10_1016_S0022_510X_97_00292_X crossref_primary_10_1016_j_transci_2007_01_012 crossref_primary_10_1016_j_patbio_2005_12_003 crossref_primary_10_1212_WNL_0b013e31827debad crossref_primary_10_2217_imt_09_67 crossref_primary_10_1016_j_intimp_2005_11_013 crossref_primary_10_1016_j_pharmthera_2004_04_002 crossref_primary_10_1111_j_1423_0410_1994_tb04544_x crossref_primary_10_1111_j_1365_2249_1993_tb03407_x crossref_primary_10_4049_jimmunol_161_7_3781 crossref_primary_10_3109_08820139609059306 crossref_primary_10_1002_lt_20594 crossref_primary_10_1111_j_1399_3046_2005_00363_x crossref_primary_10_1002__SICI_1097_4598_199911_22_11_1479__AID_MUS3_3_0_CO_2_B crossref_primary_10_1155_2016_3523057 crossref_primary_10_1196_annals_1423_052 crossref_primary_10_1111_j_1423_0410_1996_tb01345_x crossref_primary_10_1111_cei_1996_104_s1_3 crossref_primary_10_1111_j_1365_2249_2005_02834_x crossref_primary_10_1046_j_1365_3083_2000_00699_x crossref_primary_10_1016_j_iac_2008_06_004 crossref_primary_10_1016_S1246_7820_03_00035_1 crossref_primary_10_1111_j_1600_065X_1994_tb00858_x crossref_primary_10_1002__SICI_1521_4141_199806_28_06_1823__AID_IMMU1823_3_0_CO_2_F crossref_primary_10_1097_00005344_200303000_00019 crossref_primary_10_1111_j_1600_065X_2010_00910_x crossref_primary_10_1093_mr_roac057 crossref_primary_10_1016_j_autrev_2008_04_012 |
ContentType | Journal Article |
Copyright | Copyright 1992 The National Academy of Sciences of the United States of America 1992 INIST-CNRS |
Copyright_xml | – notice: Copyright 1992 The National Academy of Sciences of the United States of America – notice: 1992 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1073/pnas.89.8.3325 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1091-6490 |
EndPage | 3329 |
ExternalDocumentID | 10_1073_pnas_89_8_3325 1565623 5284216 89_8_3325 2359091 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: CA19616 – fundername: NCI NIH HHS grantid: CA42049 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29P 2AX 2FS 2WC 3O- 4.4 53G 5RE 5VS 79B 85S AACGO AAFWJ AANCE ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACIWK ACNCT ACPRK ADULT ADZLD AENEX AEUPB AEXZC AFDAS AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM ASUFR AS~ CS3 D0L DCCCD DIK DNJUQ DOOOF DU5 DWIUU E3Z EBS EJD F20 F5P FRP GX1 HGD HH5 HQ3 HTVGU HYE JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST KQ8 L7B LU7 MVM N9A NEJ N~3 O9- OK1 P-O PNE PQQKQ R.V RHF RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VOH VQA W8F WH7 WHG WOQ WOW X7M XFK XSW Y6R YKV YSK ZA5 ZCA ZCG ~02 ~KM - 02 08R 0R 1AW 55 AAPBV ABFLS ABPTK ADACO AJYGW AS DZ GJ KM OHM PQEST X XHC 692 6TJ AAUGY AAYJJ ACKIV BKOMP H13 IQODW NHB TAF YBH ADACV CGR CUY CVF ECM EIF IPSME NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c531t-9ec62a508a00285be5170000f648fec8dce7e4cc301363362e4dac47e75881a83 |
IEDL.DBID | RPM |
ISSN | 0027-8424 |
IngestDate | Tue Sep 17 21:26:35 EDT 2024 Fri Oct 25 09:15:12 EDT 2024 Fri Aug 23 00:41:45 EDT 2024 Sat Sep 28 08:36:04 EDT 2024 Sun Oct 29 17:09:56 EDT 2023 Wed Nov 11 00:29:10 EST 2020 Wed May 29 08:07:10 EDT 2019 Fri Feb 02 07:05:33 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Autoimmunity Human Autoantigen T cell receptor Peptides Constant region Variable region Beta-Peptide chain Autoantibody IgG Recognition Idiotype |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c531t-9ec62a508a00285be5170000f648fec8dce7e4cc301363362e4dac47e75881a83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.1073/pnas.89.8.3325 |
PMID | 1565623 |
PQID | 72901484 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_72901484 crossref_primary_10_1073_pnas_89_8_3325 jstor_primary_2359091 pubmedcentral_primary_oai_pubmedcentral_nih_gov_48859 pascalfrancis_primary_5284216 pubmed_primary_1565623 pnas_primary_89_8_3325 pnas_primary_89_8_3325_fulltext |
ProviderPackageCode | RNA PNE |
PublicationCentury | 1900 |
PublicationDate | 1992-04-15 |
PublicationDateYYYYMMDD | 1992-04-15 |
PublicationDate_xml | – month: 04 year: 1992 text: 1992-04-15 day: 15 |
PublicationDecade | 1990 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationTitleAlternate | Proc Natl Acad Sci U S A |
PublicationYear | 1992 |
Publisher | National Academy of Sciences of the United States of America National Acad Sciences |
Publisher_xml | – name: National Academy of Sciences of the United States of America – name: National Acad Sciences |
SSID | ssj0009580 |
Score | 1.8501697 |
Snippet | We used mapping with synthetic overlapping peptides in combination with molecular modeling to analyze the IgG antibodies that humans naturally produce against... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis pnas jstor |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3325 |
SubjectTerms | Adult Aged Amino Acid Sequence Antibodies Antigens Arthritis, Rheumatoid - immunology Autoantibodies Autoantibodies - analysis Autoantibodies - immunology Autoantigens Autoantigens - immunology Autoimmunity (experimental aspects and models) Biological and medical sciences Enzyme linked immunosorbent assay Female Fundamental and applied biological sciences. Psychology Fundamental immunology Humans Immunoglobulin constant regions Immunoglobulin G - chemistry Immunoglobulin G - immunology Immunoglobulin G - isolation & purification Immunoglobulins Immunology Lupus Erythematosus, Systemic - immunology Macromolecular Substances Male Middle Aged Models, Molecular Molecular Sequence Data Peptides - chemical synthesis Peptides - immunology Protein Conformation Reactivity Receptors, Antigen, T-Cell - genetics Receptors, Antigen, T-Cell - immunology T cell antigen receptors |
Title | Human Autoantibodies Reactive with Synthetic Autoantigens from T-Cell Receptor β Chain |
URI | https://www.jstor.org/stable/2359091 http://www.pnas.org/content/89/8/3325.abstract https://www.ncbi.nlm.nih.gov/pubmed/1565623 https://search.proquest.com/docview/72901484 https://pubmed.ncbi.nlm.nih.gov/PMC48859 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYKUiUuVaGgpuXhA1LbQ3YTPxLnWKEiWkTVA0j0ZNleR6wEzopkD_33zDiPshWnXuOHnJmx_Y3z-Qshp1lhlRCQ5BiXixQ1pVLLuEktJA-2rlGxHS8nX_0sLm7Ej1t5O9zjbgdaZXB2OQv3D7OwvIvcytWDm488sfmvqzMIOlnNt8gWhOeYoE86u6q_dcJg8RVMjDqNJZ-vgmlnCkJjxjmTO-R1jmCG8Y0dqSclIkPStGCkuv-7BSqfQuuXUOi_ZMpnu9P5W_JmgJX0az_8XfLKhz2yO0zcln4e1KW_vCO_47E9NeuuAaMubYM0QgrQMS58FM9lafsnAC6ErqZqEGYtxaso9DrFs35ogHyY5pFa3xnq7swy7JOb82_XZxfp8H-F1MHM69LKu4IZQGgGMy9pvUSxviyrC6Fq7xS8UumFcxx13TjsdF4sjBOlhxxD5UbxA7IdmuDfE8oyU8myBrxRO-ELWS2EYZny4IKyqhdZQj6NNtarXkZDx8_fJddoWa0qrTT6JSH70QVTNcZlBaAmIUcbLpnKJWywLC8SchA7Gh8_6_Dk5QJdD_QarDG4VcPkQiua4Jt1q8v4lVkJ7Dw6-e_g-9hJiNzw_lSOqt2bJRDMUb07Bu-H_2z3kez0fGGR5vKQbHePa38EqKizx5APfL88jrPhCcEJDiQ |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB1BEaIXoNCKAKU-IAGHZBN_JM4RVVQLdCsOW6mcItvrqCuod9VkD_DrGTsfdKte4JqxrcTzbM_Ez88Ab9NcS84xyVEm47HXlIo1ZSrWmDzouvaK7f5w8uwsn57zLxfioj_H3fS0Smf0MnE_rxK3vAzcyvWVmQw8scm32TGCTpST-_AAR2vKhxR9VNqV3bkTitMvp3xQaizYZO1Uk0gER8IYFbvwMPPhDGVba1JHS_QcSdVgN9Xd_RZe-xRr3xWH3qZT3lifTp7AfPiyjpbyI9m0OjG_b4k-_uOnP4XHfbxKPnbGPbhn3TPY62eEhrzvZas_PIfvYT-AqE27Qm8t9crzEwnGpGFGJf6HL2l-OQw4samxGOK3If6MC5nHfhMBK3iizeqaaNsqYi7V0u3D-cmn-fE07i9uiA0O6TYurcmpwtBP-ZROaCu8CmCa1jmXtTUSe6qw3BjmBeMYLqGWL5ThhcXkRWZKsgPYcStnXwChqSpFUWMgUxtuc1EuuKKptOjZoqwXaQTvBtdV606fowr76gWrvMMqWVay8u6OYD94dixGmSgxWorgcMvTo13gyk2zPIKD0NDw-EaDR3cbqrrn7fgSPVoqHLW-F5Wzq01TFWH7WnLfeMDO35fvIBmB2ALVaPdy4NsWhEqQBQ_QePmf9Y7g0XQ-O61OP599fQW7HSmZx5l4DTvt9cYeYujV6jdhqP0Bwd8uwQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwGLWgCNQLUGhFgFIfkIBDNi-Jc0SFUVla9dBKw8lyPLY6KnVGTeYAv57PzkKn6qnX8aKJv2f7ffHzC0Lvs6IWjEGSo3TOYu8pFdeEqriG5KG21ju2-8vJxyfF0Tn7Pufz4dVFO8gqna6Xift9lbjlRdBWrq50OurE0tPjQwAdr9LVwqYP0SOYsVkxpumT267o754QWIIZYaNbY0nTlVNtIgAgCaWEb6PHuac0hG7sS7000eskVQtDZftvXHj_U2h9Fxe9Lam8sUfNnqH5-HS9NOUyWXd1ov_eMn68x-M_R08H3oo_9xV20APjXqCdYWVo8cfBvvrTS_QrnAtgte4aiNqybrxOEQM3DSsr9i9-cfvHAfGErqZqgOMW-7su-Cz2hwnQwAtummtcm05hfaGWbhedz76eHR7FwwccYg1Tu4srowuigAIqn9rx2nDvBphltmDCGi1gtErDtKbeOI7CVmrYQmlWGkhiRK4E3UNbrnHmFcIkUxUvLRAaq5kpeLVgimTCQHTLyi6yCH0YwydXvU-HDOfrJZU-aFJUUkgf8gjthuhO1QjlFbCmCO1vRHsq57CDk7yI0F7oaPz5RocHdxdIO-h3fI0BMRJmrx9F5UyzbmUZjrEF850H_Pz_8z0sI8Q3gDWVe1vwzRKAS7AHD_B4fc92B-jJ6ZeZ_Pnt5McbtN1rk1mc87doq7tem31gYF39Lsy2fyZ7MUE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+autoantibodies+reactive+with+synthetic+autoantigens+from+T-cell+receptor+beta+chain&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Marchalonis%2C+J+J&rft.au=Kaymaz%2C+H&rft.au=Dedeoglu%2C+F&rft.au=Schluter%2C+S+F&rft.date=1992-04-15&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=89&rft.issue=8&rft.spage=3325&rft.epage=3329&rft_id=info:doi/10.1073%2Fpnas.89.8.3325&rft.externalDBID=n%2Fa&rft.externalDocID=10_1073_pnas_89_8_3325 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F89%2F8.cover.gif |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F89%2F8.cover.gif |